Le Lézard
Classified in: Health
Subject: SVY

The Global Atherectomy Devices Market Is Projected To Reach USD 1.45 Billion By 2022 From USD 1.08 Billion In 2017, At A CAGR Of 6.1%


LONDON, Nov. 21, 2017 /PRNewswire/ -- The atherectomy devices market projected to grow at a CAGR of 6.1%
The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from USD 1.08 billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

Download the full report: https://www.reportbuyer.com/product/5206169

The increasing number of research activities in the field of atherectomy and rising healthcare expenditure across emerging markets are also driving the growth of the market. However, limited patient awareness related to disease diagnosis (resulting in delayed treatment for peripheral vascular diseases), stringent regulatory framework, dearth of well-trained surgeons to conduct atherectomy procedures, and significant adoption of alternative therapies are the key challenges faced by a majority of the atherectomy device manufacturers across the globe.

"The peripheral vascular applications segment is poised to be the fastest-growing during the forecast period."
On the basis of application, the global atherectomy devices market is segmented into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular atherectomy applications segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment, rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries, and growing patient preference for minimally invasive surgical procedures

"The hospitals & surgical centers segment is expected to have the largest share of the market in 2017."
In 2017, on the basis of end user, the hospitals and surgical centers segment is expected to account for the largest share of the market. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.

"Asia Pacific is expected to register the highest growth rate during the forecast period."
Geographically, the atherectomy devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC atherectomy devices market can be attributed to the factors such as the presence of increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems.

Breakdown of supply-side primary interviews: by company type, designation, and region:

The global atherectomy devices market is competitive, with a large number of global and local players. In 2016, the market was dominated by Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Product launches, strategic acquisitions, agreements & collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage
This report studies the atherectomy devices market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis?industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the atherectomy devices market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

Download the full report: https://www.reportbuyer.com/product/5206169

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer


These press releases may also interest you

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 19:46
Although gun violence is down by 12%, gun-related homicide is up by 44%. Therefore, the City of Lauderhill is announcing a pivotal strategy to reduce gun violence and promote peace among its 75,000 residents. This plan highlights Lauderhill's...

at 18:42
Specsavers was recognized in Canada's Best Workplacestm List for 2024 by Great Place To Work®, the global authority on workplace culture. The Company is proud to rank as the highest optical retailer in the medium-sized company category after entering...

at 18:30
St. Joseph's Hospital today announced that it becomes the first health care facility to use checkout-free technology in a hospital cafeteria, demonstrating BayCare and St. Joseph's Hospital's commitment to innovation, patient care and team member...

at 17:46
Veterans with Wounded Warrior Project® (WWP) kicked off the organization's annual Soldier Ride® in the nation's capital with First Lady Jill Biden at the White House today. As part of her Joining Forces initiative to support military and veteran...

at 17:45
Tiger Aesthetics Medical, LLC today announced its acquisition of substantially all of the assets associated with the Sientra Inc. breast implant business. This strategic acquisition will complement Tiger Aesthetics' upcoming adipose cell and tissue...



News published on and distributed by: